With the aims of bypassing early lethality and analyzing SV2A’s functions in epilepsy, we thus established a conditional mouse line carrying SV2A deletion in the hippocampus, starting after P14 or, in other words, after the earliest and main postnatal stages of neurodevelopment. Here, SV2A is linked to epilepsy.